9 completed. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
Follow Foradil: new trials by email Literature Review of Foradil trials Research Report on Foradil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) Tiotropium, Salmeterol, Formoterol - Asthma | Phase 3 | Completed | Brigham and Women's Hospital | 1070 | 2011-03-30 | 2018-03-30 |
| Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease BI 1744, bi1744, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 99 | 2009-06-01 | 2014-07-01 |
| Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease BI 1744 (Olodaterol) Low Dose, BI 1744 (Olodaterol) Medium Dose, Placebo - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 100 | 2009-06-01 | 2016-02-05 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in COPD (Study P04229AM4)(COMPLETED) Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | Organon and Co | 1055 | 2006-10-01 | 2024-05-20 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED) mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg, formoterol fumarate 10 mcg - Asthma | Phase 3 | Completed | Organon and Co | 781 | 2006-09-01 | 2024-05-20 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED) Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol Fumarate 10 mcg - Asthma | Phase 3 | Completed | Organon and Co | 746 | 2006-09-01 | 2024-05-17 |
| Effects of Mometasone Furoate/Formoterol Combination Versus Formoterol and Mometasone Furoate Alone in Chronic Obstructive Pulmonary Disease (COPD) (Study P04230AM4)(COMPLETED) Mometasone furoate/formoterol (MF/F) combination, Mometasone furoate MDI (MF MDI), Formoterol MDI - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | Organon and Co | 1196 | 2006-09-01 | 2024-05-23 |
| Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease Arformoterol tartrate inhalation solution, Arformoterol 25 ųg BID, Formoterol 12 ųg BID - Chronic Obstructive Pulmonary Disease, Bronchitis | Phase 3 | Completed | Sumitomo Pharma America, Inc. | 443 | 2005-10-01 | 2012-06-04 |
| Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients Formoterol - Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Chiesi Farmaceutici S.p.A. | 457 | 2005-08-01 | 2011-12-13 |
Pulmonary Disease, Chronic Obstructive (6) · Asthma (3) · Bronchitis (1) · Bronchitis, Chronic (1) · Emphysema (1)
Organon and Co (4) · Boehringer Ingelheim (2) · Brigham and Women's Hospital (1) · Chiesi Farmaceutici S.p.A. (1) · Sumitomo Pharma America, Inc. (1)
United States (4) · Poland (1)
Elliot Israel, MD (1) · Iwona Graelewska Rzymowska, Prof (1)
PMID 22334770, PMID 25044280, PMID 25187881, PMID 20678306, PMID 21828036, PMID 22334768, PMID 22334769, PMID 26505596, PMID 36472162